
Queensland researchers will lead a trial of a game-changing flu vaccine that could mean the end of the annual flu jab.
Conventional flu vaccines are regularly modified to target virus mutations, but the vaccine being trialled by Brisbane’s Mater Research could provide broader protection for longer.